CLINICAL STUDY: PEDIATRIC CARDIOLOGY
The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients
Douglas D. Mair, MD, FACC*,
Francisco J. Puga, MD, FACC and
Gordon K. Danielson, MD, FACC
* Section of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA
Manuscript received June 21, 2000;
revised manuscript received September 20, 2000,
accepted November 3, 2000.
Reprint requests and correspondence: Dr. Douglas D. Mair, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 mair.douglas{at}mayo.edu
OBJECTIVES
We assessed the operative and late mortality and the present clinical status of 216 patients with tricuspid atresia who had a nonfenestrated Fontan procedure performed at the Mayo Clinic in the 25-year period 1973 to 1998.
BACKGROUND
The Fontan operation eliminates the systemic hypoxemia and ventricular volume overload characteristic of prior forms of palliation. However, it originally did so at the cost of systemic venous and right atrial hypertension, and the long-term effects of this "price" were unknown when the procedure was initially proposed.
METHODS
We reviewed the clinical records of the 216 patients retrospectively. These were arbitrarily grouped into early (1973 through 1980), middle (1981 through 1987) and late (1988 through 1997) surgical eras. Patient outcome was also analyzed according to age at surgery. Operative and late mortality rates were determined and present clinical status was ascertained in 167 of 171 surviving patients.
RESULTS
Overall survival was 79%. Operative mortality steadily declined and was 2% (one of 58 patients) during the most recent decade. Late survival also continues to improve. Age at operation had no effect on operative mortality, and late mortality was significantly increased only in patients who were operated on at age 18 years or older. Eighty-nine percent of surviving patients are currently in New York Heart Association class I or II.
CONCLUSIONS
The initial 25-year experience with the nonfenestrated Fontan procedure for tricuspid atresia has been gratifying, with most survivors now leading lives of good quality into adulthood. These results justify continued application of this procedure for children born with tricuspid atresia.
|
Abbreviations and Acronyms
| | LV | = left ventricular | | NYHA | = New York Heart Association | | PA | = pulmonary artery | | RA | = right atrium | | RV | = right ventricle, right ventricular |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Silvilairat, Y. Pongprot, R. Sittiwangkul, S. Woragidpoonpol, S. Chuaratanaphong, and W. Nawarawong
Factors Influencing Survival in Patients After Bidirectional Glenn Shunt
Asian Cardiovasc Thorac Ann,
October 1, 2008;
16(5):
381 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Camposilvan, O. Milanesi, G. Stellin, A. Pettenazzo, L. Zancan, and L. D'Antiga
Liver and Cardiac Function in the Long Term After Fontan Operation
Ann. Thorac. Surg.,
July 1, 2008;
86(1):
177 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Whitehead, K. Pekkan, H. D. Kitajima, S. M. Paridon, A. P. Yoganathan, and M. A. Fogel
Nonlinear Power Loss During Exercise in Single-Ventricle Patients After the Fontan: Insights From Computational Fluid Dynamics
Circulation,
September 11, 2007;
116(11_suppl):
I-165 - I-171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Bartz, D. J. Driscoll, J. A. Dearani, F. J. Puga, G. K. Danielson, P. W. O'Leary, M. G. Earing, C. A. Warnes, D. O. Hodge, and F. Cetta
Early and Late Results of the Modified Fontan Operation for Heterotaxy Syndrome: 30 Years of Experience in 142 Patients
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2301 - 2305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Guleserian, L. B. Armsby, R. R. Thiagarajan, P. J. del Nido, and J. E. Mayer Jr
Natural History of Pulmonary Atresia With Intact Ventricular Septum and Right-Ventricle-Dependent Coronary Circulation Managed by the Single-Ventricle Approach
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
2250 - 2258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Alphonso, M. Baghai, P. Sundar, R. Tulloh, C. Austin, and D. Anderson
Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis
Eur. J. Cardiothorac. Surg.,
October 1, 2005;
28(4):
529 - 535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Mahle, J. M. Forbess, P. M. Kirshbom, A. R. Cuadrado, J. M. Simsic, and K. R. Kanter
Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children
J. Thorac. Cardiovasc. Surg.,
May 1, 2005;
129(5):
1084 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Nicolas, C. Hills, J. H. Moller, C. B. Huddleston, and M. C. Johnson
Early Outcome After Glenn Shunt and Fontan Palliation and the Impact of Operation During Viral Respiratory Season: Analysis of a 19-year Multi-Institutional Experience
Ann. Thorac. Surg.,
February 1, 2005;
79(2):
613 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Petko, R. J. Myung, G. Wernovsky, M. I. Cohen, J. Rychik, S. C. Nicolson, J. W. Gaynor, and T. L. Spray
Surgical reinterventions following the Fontan procedure
Eur. J. Cardiothorac. Surg.,
August 1, 2003;
24(2):
255 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Khambadkone, J. Li, M.R. de Leval, S. Cullen, J.E. Deanfield, and A.N. Redington
Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation
Circulation,
July 1, 2003;
107(25):
3204 - 3208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Burkhart, J. A. Dearani, D. D. Mair, C. A. Warnes, C. C. Rowland, H. V. Schaff, F. J. Puga, and G. K. Danielson
The modified Fontan procedure: Early and late results in 132 adult patients
J. Thorac. Cardiovasc. Surg.,
June 1, 2003;
125(6):
1252 - 1259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Levy, C. Danel, A.-M. Laval, F. Leca, P. R. Vouhe, and D. Israel-Biet
Nitric oxide synthase expression by pulmonary arteries: A predictive marker of Fontan procedure outcome?
J. Thorac. Cardiovasc. Surg.,
May 1, 2003;
125(5):
1083 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Seipelt, A. Franke, J. F. Vazquez-Jimenez, P. Hanrath, G. von Bernuth, B. J. Messmer, and E. G. Muhler
Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches
Ann. Thorac. Surg.,
August 1, 2002;
74(2):
556 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|